Welcome to our dedicated page for Elite Hlth Sys SEC filings (Ticker: EHSI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Elite Hlth Sys's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Elite Hlth Sys's regulatory disclosures and financial reporting.
Elite Health Systems Inc. reported the results of a Special Meeting of Stockholders held on September 26, 2025. A total of 21,939,924 common shares were eligible to vote, and 14,688,791 votes were cast, establishing a quorum.
Stockholders voted on director nominees and additional proposals. Director vote totals disclosed include: Dr. Prasad Jeereddi with 14,632,106 votes for and 56,685 against; Alan Gold with 14,633,106 for and 55,685 against; William Leimkuhler with 14,633,106 for and 55,685 against; William St. Lawrence with 14,633,106 for and 55,685 against; and Dr. Haranath Policherla with 14,688,791 for, 0 against, and 0 abstentions.
The filing also lists proposal vote counts as follows: 14,487,901 for and 200,890 against; 14,497,016 for and 191,775 against; 14,031,106 for, 157,685 against, and 500,000 abstentions; 14,688,791 for, 0 against, and 0 abstentions; and 14,622,906 for and 65,885 against.
Elite Health Systems Inc. discloses an acquisition agreement involving its Chief Executive Officer, Dr. Prasad Anjaneya Jeereddi, and his daughter, Dr. Praveena Jeereddi, identified as the selling stockholders. The filing states Dr. Jeereddi served as a principal executive officer from